Terms: = Breast cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Clinical Outcome
4 results:
1. A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The cancer Genome Atlas (TCGA) dataset.
Jang BS; Kim IA
Radiother Oncol; 2017 Sep; 124(3):403-410. PubMed ID: 28579282
[TBL] [Abstract] [Full Text] [Related]
2. Surgical treatment for mediastinal parathyroid adenoma causing primary hyperparathyroidism.
Kitada M; Yasuda S; Nana T; Ishibashi K; Hayashi S; Okazaki S
J Cardiothorac Surg; 2016 Apr; 11():44. PubMed ID: 27056365
[TBL] [Abstract] [Full Text] [Related]
3. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
[TBL] [Abstract] [Full Text] [Related]
4. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract] [Full Text] [Related]
